Satyapal Rangaraj

787 total citations
17 papers, 265 citations indexed

About

Satyapal Rangaraj is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Hematology. According to data from OpenAlex, Satyapal Rangaraj has authored 17 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Rheumatology and 7 papers in Hematology. Recurrent topics in Satyapal Rangaraj's work include Autoimmune and Inflammatory Disorders Research (7 papers), Cystic Fibrosis Research Advances (4 papers) and Adolescent and Pediatric Healthcare (3 papers). Satyapal Rangaraj is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (7 papers), Cystic Fibrosis Research Advances (4 papers) and Adolescent and Pediatric Healthcare (3 papers). Satyapal Rangaraj collaborates with scholars based in United Kingdom, United States and Türkiye. Satyapal Rangaraj's co-authors include Clarissa Pilkington, Joyce Davidson, Michael W. Beresford, Judith Thornton, J. E. R. McDonagh, Eileen Baildam, Janet Gardner‐Medwin, Gavin Cleary, Valentina Leone and Neil Archer and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Lara D. Veeken and Seminars in Arthritis and Rheumatism.

In The Last Decade

Satyapal Rangaraj

14 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satyapal Rangaraj United Kingdom 7 166 93 70 54 52 17 265
Donatella Ventura Italy 6 247 1.5× 104 1.1× 93 1.3× 28 0.5× 76 1.5× 11 316
Ann Igoe United States 6 162 1.0× 110 1.2× 29 0.4× 28 0.5× 70 1.3× 7 307
Jean‐Loup Pennaforte France 10 204 1.2× 82 0.9× 36 0.5× 57 1.1× 38 0.7× 20 314
M. Frigui Tunisia 12 202 1.2× 76 0.8× 37 0.5× 70 1.3× 46 0.9× 41 349
Natasha Jordan United Kingdom 9 131 0.8× 80 0.9× 33 0.5× 33 0.6× 24 0.5× 23 216
A.R. Villa Mexico 8 314 1.9× 93 1.0× 59 0.8× 85 1.6× 65 1.3× 9 384
Judith Payet France 11 177 1.1× 67 0.7× 38 0.5× 15 0.3× 48 0.9× 13 289
Jessie Risse France 9 205 1.2× 37 0.4× 37 0.5× 40 0.7× 135 2.6× 25 325
R. Pappu United States 5 235 1.4× 97 1.0× 57 0.8× 36 0.7× 111 2.1× 7 447
Neslihan Yılmaz Türkiye 10 166 1.0× 109 1.2× 53 0.8× 152 2.8× 24 0.5× 30 344

Countries citing papers authored by Satyapal Rangaraj

Since Specialization
Citations

This map shows the geographic impact of Satyapal Rangaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satyapal Rangaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satyapal Rangaraj more than expected).

Fields of papers citing papers by Satyapal Rangaraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satyapal Rangaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satyapal Rangaraj. The network helps show where Satyapal Rangaraj may publish in the future.

Co-authorship network of co-authors of Satyapal Rangaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Satyapal Rangaraj. A scholar is included among the top collaborators of Satyapal Rangaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satyapal Rangaraj. Satyapal Rangaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brogan, Paul, Gavin Cleary, Aimee O. Hersh, et al.. (2022). Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis. Rheumatology and Therapy. 9(2). 721–734. 2 indexed citations
2.
3.
Smith, Eve, Sarah L. Gorst, Eslam Al‐Abadi, et al.. (2021). ‘It is good to have a target in mind’: qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus. Lara D. Veeken. 60(12). 5630–5641. 12 indexed citations
4.
Brogan, Paul, Rae S. M. Yeung, Gavin Cleary, et al.. (2021). Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis. Arthritis & Rheumatology. 74(1). 124–133. 17 indexed citations
5.
Rangaraj, Satyapal, et al.. (2019). P48 The puppet prescriber or custodian of the NHS purse: are patients really at the centre of what we do?. Lara D. Veeken. 58(Supplement_4).
6.
Rooney, Madeleine, Nick Bishop, Joyce Davidson, et al.. (2019). The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. EClinicalMedicine. 12. 79–87. 29 indexed citations
7.
Chan, Alice, et al.. (2017). 047. Idiopathic uveitis – A paediatric cohort. Lara D. Veeken. 56(suppl_6). 1 indexed citations
8.
Thornton, Judith & Satyapal Rangaraj. (2016). Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis. Cochrane Database of Systematic Reviews. 2021(4). CD006838–CD006838. 9 indexed citations
9.
Rangaraj, Satyapal, et al.. (2015). PP13. Intravenous methotrexate: a single-centre experience. Lara D. Veeken. 54(suppl_2). ii10–ii10.
10.
McCrea, Nadine, et al.. (2014). Onset of juvenile dermatomyositis following varicella infection in a 12-month-old child: a case report. Journal of Medical Case Reports. 8(1). 4 indexed citations
11.
Thornton, Judith & Satyapal Rangaraj. (2012). Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis. Cochrane Database of Systematic Reviews. CD006838–CD006838. 5 indexed citations
12.
Hawley, Daniel, Eileen Baildam, Tania Amin, et al.. (2012). Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK. Lara D. Veeken. 51(7). 1235–1239. 23 indexed citations
13.
Watson, L., Valentina Leone, Clarissa Pilkington, et al.. (2012). Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohort. Arthritis & Rheumatism. 64(7). 2356–2365. 149 indexed citations
14.
Thornton, Judith & Satyapal Rangaraj. (2012). Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis. Cochrane Database of Systematic Reviews. 2017(6). CD007336–CD007336. 2 indexed citations
15.
Hawley, Daniel, et al.. (2010). British Isles Survey of Methotrexate Monitoring Practice During Treatment of Juvenile Idiopathic Arthritis. Seminars in Arthritis and Rheumatism. 40(4). 358–364.e2. 2 indexed citations
16.
Thornton, Judith & Satyapal Rangaraj. (2008). Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis. Cochrane Database of Systematic Reviews. CD006838–CD006838. 3 indexed citations
17.
Tattersall, Rachel & Satyapal Rangaraj. (2008). Diagnosing juvenile idiopathic arthritis. Paediatrics and Child Health. 18(2). 85–89. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donatella Ventura Breakdown of academic impact, for papers by Ann Igoe Breakdown of academic impact, for papers by Jean‐Loup Pennaforte Breakdown of academic impact, for papers by M. Frigui Breakdown of academic impact, for papers by Natasha Jordan Breakdown of academic impact, for papers by A.R. Villa Breakdown of academic impact, for papers by Judith Payet Breakdown of academic impact, for papers by Jessie Risse Breakdown of academic impact, for papers by R. Pappu Breakdown of academic impact, for papers by Neslihan Yılmaz
Rankless by CCL
2026